Skip to main content
Clinical Trials/NCT02939612
NCT02939612
Active, not recruiting
Not Applicable

Testing a Computerized Interactive Stress Management Intervention in Early Stage Cancer: a Randomized Controlled Trial

Oslo University Hospital1 site in 1 country200 target enrollmentOctober 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Oslo University Hospital
Enrollment
200
Locations
1
Primary Endpoint
The Perceived Stress Scale (PSS-14)
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The purpose with this study is to test the effect of an app for stress management among patients with a variety of cancer diagnoses.

Detailed Description

A cancer diagnosis and subsequent treatment can be disruptive and traumatic, often accompanied by a multitude of stressors for the patients and their support network. Uncertainty of outcome and invasive medical procedures with aversive side effects are not uncommon, and while people differ widely in how they experience and cope with such challenges, cancer related distress including anxiety, depression, worry and rumination is prevalent. With multiple domains of function impacted it is also not surprising that quality of life (QoL) often is diminished. Stress management interventions can facilitate adjustment to cancer, including reduced distress and improved quality of life. Unfortunately, many people with cancer do not have the strength or opportunity to attend groups or in-person interventions. This study will therefore test the effect of an app for stress management among patients with different cancer diagnosis. The app contains 10 modules distributed over five weeks, focusing on education of different techniques for reduction of stress and stress reduction exercises. The app was tested in a feasibility pilot study among 25 patients with a variety of cancer diagnoses and is now being tested in a randomized controlled trial with a sample of 175 cancer survivors. The participants were randomly assigned to use the 10 module app or to a control group that receive treatment as usual, and will be followed with repeated measures over 12 months.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Lise Solberg Nes

Head of Department

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with cancer (all diagnosis).
  • Maximum time since completed treatment at hospital: 12 months
  • Patients are \> 18 years of age, able to write/read/speak Norwegian and have their own smart phone or tablet

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The Perceived Stress Scale (PSS-14)

Time Frame: Baseline, post intervention follow up at 3, 6, and 12 months

14 item scale measuring perceived stress. Scale range: 0-56. Higher scores indicate higher perceived stress.

Secondary Outcomes

  • SF-36 Item Short Form Health Survey (RAND-36 version)(Baseline, post intervention follow up at 3, 6, and 12 months)
  • The Brief Coping Orientation to Problems (Brief COPE)(Baseline)
  • The Distress Thermometer(Baseline, post intervention follow up at 3, 6, and 12 months)
  • Health, well-being and sleep(Baseline, post intervention follow up at 3, 6, and 12 months)
  • The Self-Regulatory Fatigue-18 (SRF-18)(Baseline, post intervention follow up at 3 and 12 months)
  • The Hospital Anxiety and Depression Scale (HADS)(Baseline, post intervention follow up at 3, 6, and 12 months)
  • Intervention commentary(Post intervention (immediately post intervention))

Study Sites (1)

Loading locations...

Similar Trials